(NAMI) Jinxin Technology Holding - Ratings and Ratios
DigitalTextbooks, EducationalContent, LearningApp
NAMI EPS (Earnings per Share)
NAMI Revenue
Description: NAMI Jinxin Technology Holding
Jinxin Technology Holding Company is a digital content service provider in China, offering digital textbooks and educational content primarily through its Namibox learning app, telecom and broadcast operators, and third-party devices. The companys focus on K-9 education suggests a strong potential for growth in Chinas large and expanding education market.
Analyzing the companys position in the Education Services sub-industry, we can observe that its market capitalization stands at $259.37 million, indicating a relatively small-cap stock. The Price-to-Earnings ratio of 28.93 suggests that the stock may be moderately overvalued, while the Return on Equity of 28.97% indicates a strong ability to generate profits from shareholder equity.
To further evaluate NAMIs potential, we can consider additional KPIs such as revenue growth rate, customer acquisition cost, and user engagement metrics. For instance, the growth rate of Namiboxs user base and the average revenue per user (ARPU) could provide valuable insights into the companys ability to scale and monetize its user base. Furthermore, metrics such as customer retention rate and the ratio of digital content sales to overall revenue could help assess the companys competitive position and operational efficiency.
From a competitive landscape perspective, its essential to analyze NAMIs market share, competitor analysis, and the overall outlook for the Chinese education technology market. Factors such as government regulations, technological advancements, and shifting consumer preferences will likely impact NAMIs future performance. By examining these factors and monitoring key performance indicators, we can better understand NAMIs potential for long-term growth and profitability.
NAMI Stock Overview
| Market Cap in USD | 259m |
| Sub-Industry | Education Services |
| IPO / Inception | 2024-12-06 |
NAMI Stock Ratings
| Growth Rating | -63.5 |
| Fundamental | 73.4% |
| Dividend Rating | - |
| Rel. Strength | -78.8 |
| Analysts | - |
| Fair Price Momentum | 0.78 USD |
| Fair Price DCF | 3.33 USD |
NAMI Dividends
Currently no dividends paidNAMI Growth Ratios
| Growth Correlation 3m | -86.9% |
| Growth Correlation 12m | -86.7% |
| Growth Correlation 5y | -86.7% |
| CAGR 5y | -76.35% |
| CAGR/Max DD 5y | -0.91 |
| Sharpe Ratio 12m | -1.33 |
| Alpha | -71.99 |
| Beta | -0.630 |
| Volatility | 182.07% |
| Current Volume | 17k |
| Average Volume 20d | 27.8k |
| Stop Loss | 0.9 (-14.3%) |
| Signal | -0.35 |
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (20.3m TTM) > 0 and > 6% of Revenue (6% = 24.4m TTM) |
| FCFTA 0.10 (>2.0%) and ΔFCFTA -9.09pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 21.60% (prev 38.97%; Δ -17.37pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 25.8m > Net Income 20.3m (YES >=105%, WARN >=100%) |
| Net Debt (-87.1m) to EBITDA (56.7m) ratio: -1.54 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.17 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (28.7m) change vs 12m ago 10.65% (target <= -2.0% for YES) |
| Gross Margin 28.78% (prev 43.10%; Δ -14.32pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 184.9% (prev 150.3%; Δ 34.65pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| error: Interest Coverage Ratio cannot be calculated (needs EBITDA TTM and Interest Expense TTM) |
Altman Z'' -0.52
| (A) 0.36 = (Total Current Assets 162.6m - Total Current Liabilities 74.8m) / Total Assets 243.3m |
| (B) -0.59 = Retained Earnings (Balance) -143.6m / Total Assets 243.3m |
| (C) 0.12 = EBIT TTM 27.1m / Avg Total Assets 219.7m |
| (D) -1.71 = Book Value of Equity -135.7m / Total Liabilities 79.5m |
| Total Rating: -0.52 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 73.39
| 1. Piotroski 4.50pt = -0.50 |
| 2. FCF Yield 1.39% = 0.70 |
| 3. FCF Margin 6.06% = 1.51 |
| 4. Debt/Equity 0.06 = 2.50 |
| 5. Debt/Ebitda 0.13 = 2.49 |
| 6. ROIC - WACC 336.8% = 12.50 |
| 7. RoE 28.97% = 2.41 |
| 8. Rev. Trend 54.68% = 2.73 |
| 9. Rev. CAGR 12.40% = 1.55 |
| 10. EPS Trend data missing |
| 11. EPS CAGR -56.66% = -2.50 |
What is the price of NAMI shares?
Over the past week, the price has changed by +7.14%, over one month by +2.44%, over three months by -58.82% and over the past year by -76.35%.
Is Jinxin Technology Holding a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NAMI is around 0.78 USD . This means that NAMI is currently overvalued and has a potential downside of -25.71%.
Is NAMI a buy, sell or hold?
What are the forecasts/targets for the NAMI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 0.8 | -20% |
Last update: 2025-08-05 05:13
NAMI Fundamental Data Overview
CCE Cash And Equivalents = 101.7m CNY (Cash And Short Term Investments, last quarter)
P/E Trailing = 28.9286
P/S = 0.6359
Beta = None
Revenue TTM = 406.4m CNY
EBIT TTM = 27.1m CNY
EBITDA TTM = 56.7m CNY
Long Term Debt = 4.66m CNY (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 2.65m CNY (from shortTermDebt, last quarter)
Debt = 7.30m CNY (Calculated: Short Term 2.65m + Long Term 4.66m)
Net Debt = -87.1m CNY (from netDebt column, last quarter)
Enterprise Value = 1.77b CNY (1.86b + Debt 7.30m - CCE 101.7m)
Interest Coverage Ratio = unknown (Ebit TTM 27.1m / Interest Expense TTM 0.0)
FCF Yield = 1.39% (FCF TTM 24.6m / Enterprise Value 1.77b)
FCF Margin = 6.06% (FCF TTM 24.6m / Revenue TTM 406.4m)
Net Margin = 4.99% (Net Income TTM 20.3m / Revenue TTM 406.4m)
Gross Margin = 28.78% ((Revenue TTM 406.4m - Cost of Revenue TTM 289.5m) / Revenue TTM)
Tobins Q-Ratio = -13.04 (set to none) (Enterprise Value 1.77b / Book Value Of Equity -135.7m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 7.30m)
Taxrate = 0.0% (from yearly Tax Provision: 0.0 / 30.6m)
NOPAT = 27.1m (EBIT 27.1m * (1 - 0.00%))
Current Ratio = 2.17 (Total Current Assets 162.6m / Total Current Liabilities 74.8m)
Debt / Equity = 0.06 (Debt 7.30m / last Quarter total Stockholder Equity 132.0m)
Debt / EBITDA = 0.13 (Net Debt -87.1m / EBITDA 56.7m)
Debt / FCF = 0.30 (Debt 7.30m / FCF TTM 24.6m)
Total Stockholder Equity = 70.0m (last 4 quarters mean)
RoA = 8.33% (Net Income 20.3m, Total Assets 243.3m )
RoE = 28.97% (Net Income TTM 20.3m / Total Stockholder Equity 70.0m)
RoCE = 36.33% (Ebit 27.1m / (Equity 70.0m + L.T.Debt 4.66m))
RoIC = 340.5% (NOPAT 27.1m / Invested Capital 7.96m)
WACC = 3.68% (E(1.86b)/V(1.87b) * Re(3.69%)) + (D(7.30m)/V(1.87b) * Rd(0.0%) * (1-Tc(0.0)))
Shares Correlation 5-Years: 50.0 | Cagr: 3.43%
Discount Rate = 3.69% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 72.03% ; FCFE base≈29.8m ; Y1≈21.0m ; Y5≈11.1m
Fair Price DCF = 3.33 (DCF Value 213.0m / Shares Outstanding 64.0m; 5y FCF grow -34.67% → 3.0% )
Revenue Correlation: 54.68 | Revenue CAGR: 12.40%
Revenue Growth Correlation: -86.60%
EPS Correlation: N/A | EPS CAGR: -56.66%
EPS Growth Correlation: -86.60%
Additional Sources for NAMI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle